Login
| TI Ref No : | 523878665 |
|---|---|
| Description : | Contract Awarded For Palivizumab the Medicine Is Used To Prevent Serious Lower Respiratory Disease Requiring Hospitalization, Which Is Caused By A Respiratory Syncycial Virus (rsv) In Children With A High Risk Of Rsv. This Medicine Is Administered Seasona |
| Date : | 2025-10-14 |
| Deadline : | 2026-01-03 |
| Document Type : | Contracts |
